If you’re not too early, you’re too late | Shelby Newsad, Partner at Compound VC
A conversation with Shelby Newsad PhD, Partner at Compound.
Anastasia Janas
Check out the latest posts
Rewriting Genetic Medicine with Epigenetic Editing | Dr. Catherine Stehman-Breen, former CEO of Chroma Medicine
A conversation with Dr. Catherine Stehman-Breen, former CEO of Chroma Medicine.
Unlocking the power of the gut microbiome with AI
A conversation with Leo Grady PhD, founder and CEO of Jona.
Biotech journalism & scaling new heights for a good cause
A conversation with Luke Timmerman, award-winning biotech journalist and founder of the Timmerman Report.